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Abst ract
Background and purpose: Reactive oxygen species play an
important role in the physiology and pathology of cerebral
arteries, including ischaemic stroke. The cytochrome b-245
alpha gene (CYBA) encodes cytochrome b-245 alpha light
chain (p22phox peptide), a critical element of NAD(P)H
oxidases, the most important source of superoxide anion in
the cerebral arteries. To search for genetic factors associated
with paediatric ischaemic stroke, the possible association
between CYBA gene C242T polymorphism and the disease
was evaluated.
Material and methods: The study group consisted of 238 in -
dividuals: children with ischaemic stroke (n = 70), their bio-
logical parents (n = 118) and children without any symp-
toms of stroke (n = 50). The C242T polymorphism was
genotyped using polymerase chain reaction – restriction frag-
ment length methodology. To evaluate the possible associa-
tion between polymorphism and stroke, the transmission dise-
quilibrium test and the case-control method were applied.
Results: The C242 allele was transmitted more frequently
than 242T (62.2% vs. 37.8%) but observed frequencies did
The C242T polymorphism of the gene encoding cytochrome b-245 alpha is not
associated with paediatric ischaemic stroke: family-based and case-control study
Polimorfizm C242T genu koduj¹cego cytochrom b-245 alfa nie jest zwi¹zany z udarem 
niedokrwiennym mózgu u dzieci: analiza wewn¹trzrodzinna i badanie kliniczno-kontrolne 
Pawe³ Niemiec1, Iwona ¯ak1, Ewa Emich-Widera2, Anna Balcerzyk1, Ilona Kopyta2, Tomasz Nowak1, Jerzy Wendorff3, 
Katarzyna Pa³atyñska3, Marek Kaciñski4, Karolina Pienczk-Rêc³awowicz5, Ewa Pilarska5
1Department of Biochemistry and Medical Genetics, School of Health Care, Medical University of Silesia, Katowice, Poland
2Department of Neuropaediatrics, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
3Department of Neurology, Polish Mother’s Memorial Hospital – Research Institute, £ódŸ, Poland
4Department of Paediatric and Adolescent Neurology, Medical College, Jagiellonian University, Kraków, Poland
5Department of Developmental Neurology, School of Medicine, Medical University of Gdansk, Gdañsk, Poland
Neurologia i Neurochirurgia Polska 2010; 44, 5: 453–458
ORIGINAL PAPER/ARTYKU£ ORYGINALNY
St reszc zenie
Wstêp i cel pracy: Reaktywne formy tlenu pe³ni¹ istotn¹ funkcjê
zarówno w fizjologii, jak i patologii têtnic mózgowych, tak¿e
w patogenezie udaru niedokrwiennego mózgu. Gen cyto-
chromu b-245 alfa (gen CYBA) koduje lekki ³añcuch cyto-
chromu b-245 (bia³ko p22phox), kluczowy sk³adnik oksydaz
NAD(P)H, najwa¿niejszego Ÿród³a anionorodnika ponad-
tlenkowego w obrêbie têtnic mózgowych. W niniejszej pra-
cy, poszukuj¹c genetycznych czynników ryzyka predyspo-
nuj¹cych do udaru mózgu u dzieci, oceniano mo¿liwe zwi¹zki
pomiêdzy polimorfizmem C242T genu CYBA i chorob¹.  
Materia³ i metody:W badaniu wziê³o udzia³ 238 osób: 70 dzie-
ci z udarem niedokrwiennym mózgu, 118 ich biologicznych
rodziców oraz 50 dzieci bez ¿adnych objawów udaru. Polimor-
fizm C242T genu CYBA genotypowano metod¹ polimorfizmu
d³ugoœci fragmentów restrykcyjnych w reakcji ³añcuchowej poli-
merazy. Do oceny mo¿liwych zwi¹zków pomiêdzy polimorfi-
zmem i udarem zastosowano dwie niezale¿ne metody:
wewn¹trzrodzinny test transmisji i badanie kliniczno-kontrolne.
Wyniki: Allel C242 by³ czêœciej przekazywany chorym dzie-
ciom przez heterozygotycznych rodziców ni¿ allel 242T
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not differ significantly from expected (p = 0.10). There were
also no significant differences in allele and genotype distri-
bution between patients and control subjects (patients: CC –
50.0%, CT – 38.6%, TT – 11.4% vs. controls: CC – 52.0%,
CT – 36.0%, TT – 12.0%). 
Conclusions: The study did not show that the C242T poly-
morphism of the CYBA gene is a risk factor of ischaemic stro-
ke in children.
Key words: ischaemic stroke, paediatric stroke, polymorphism,
CYBA gene, free radicals, NAD(P)H oxidases.
(62,2% w porównaniu z 37,8%), jednak obserwowane czêsto-
œci nie odbiega³y znamiennie od oczekiwanych (p = 0,10).
Nie wykazano tak¿e znacz¹cych ró¿nic w rozk³adzie alleli
i genotypów pomiêdzy pacjentami i dzieæmi z grupy kon trol -
nej (pacjenci: CC – 50,0%, CT – 38,6%, TT – 11,4%; gru-
pa kontrolna: CC – 52,0%, CT – 36,0%, TT – 12,0%).
Wnioski: Wyniki badañ nie wykaza³y, aby polimorfizm
C242T genu CYBA by³ czynnikiem ryzyka udaru niedo-
krwiennego u dzieci.
S³owa kluczowe: udar niedokrwienny, udar dzieciêcy, poli-
morfizm, gen CYBA, wolne rodniki, oksydazy NAD(P)H.
Introduction
Paediatric ischaemic stroke has a multifactorial and
certainly multigenic inheritance pattern [1]. The main
causes of paediatric ischaemic stroke are cerebral arte-
riopathies, cardiac diseases, traumas, infections, meta-
bolic and mitochondrial diseases, as well as other vario-
us conditions. It is also generally accepted that ischaemic
stroke in children often has a thrombotic background,
as a result of endothelial dysfunction and various disor-
ders of blood coagulation cascade elements, manifested
by hypercoagulability [1,2]. Although atherosclerosis
is the main cause of cerebrovascular insufficiency of
adult ischaemic stroke patients [3], it seems to be rather
marginal in paediatric stroke and limited only to rare
monogenic disorders such as familial hypercholestero-
laemia. In fact, some classical risk factors of adult stro-
ke such as hypercholesterolaemia or hypertension are
relatively common in paediatric patients [4,5] and most
children have several potential risk factors rather than
one single cause, although up to 50% of all cases are
cryptogenic [2].
There is growing evidence for the role of reactive oxy-
gen species (ROS) in the physiology as well as patholo-
gy of cerebral arteries, including ischaemic stroke. ROS
serve as important cell-signalling molecules in the cere-
bral circulation and play an important role in cerebrova-
scular tone regulation [6,7]. In the pathological state
reactive oxygen species may disrupt redox balance into
the vessel wall, leading to vasoconstriction, endothelial
dysfunction, and atherosclerotic plaque formation [8-10].
Furthermore, ROS are involved in the initiation of the
blood coagulation cascade [11] and platelet activation
[12]. Focal brain ischaemia occurring after stroke has
also been shown to be associated with ROS-mediated
reactions potentially leading to neuronal death [13].
The superoxide anion is the major vascular ROS, in
both cerebral and non-cerebral arteries, and the vascu-
lar NAD(P)H oxidases are the main source of super -
oxide in the vasculature [6-9]. NAD(P)H oxidases are
a group of multisubunit enzymes catalyzing the pro-
duction of superoxide from oxygen [6-9]. They are pre-
sent in many types of cells including endothelial and
vascular smooth muscle cells of cerebral arteries
[8-10,14] and are located in the plasma membranes,
consisting of at least six components: membrane bound
catalytic NOX subunit (NOX-NADPH oxidase) and
p22phox (phox-phagocyte oxidase), as well as cytosolic
p47phox, p67phox, p40phox and small G protein Rac.
p22phox is a common element of mammalian
NAD(P)H oxidases, serving as a link between NOX
peptide and cytosolic phox subunits [8-10]. p22phox is
encoded by the cytochrome b-245 alpha (CYBA) gene
(16q24) [15]. The transition of C to T in the 242 nuc-
leotide position of the CYBA gene is associated with
conversion of histidine to tyrosine in a 72 amino acid
residue, located in the cytosolic loop of p22phox pepti-
de, and influences superoxide production.
To date, there are no studies concerning the CYBA
C242T polymorphism in paediatric ischaemic stroke
patients. Therefore in the present work we investigated
whether the CYBA polymorphism is associated with the
ischaemic stroke risk in children, using two different
methods: a family-based association test and the case-
control model.
Material and methods
Subjects
The study group consisted of 238 individuals, in -
cluding 70 children with ischaemic stroke, their biolo-
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gical parents (n = 118), and 50 children without any
symptoms of ischaemic stroke. There were 41 males and
29 females in the patient group, and their age at the acu-
te phase of stroke ranged from 6 months to 18 years
(mean 8.4 ± 5.3). Participants were recruited from the
Department of Neuropaediatrics at the Medical Uni-
versity of Silesia in Katowice, the Department of Neuro-
logy at the Polish Mother’s Memorial Hospital in Lodz,
the Department of Developmental Neurology at the
Medical University of Gdansk and the Department of
Paediatric and Adolescent Neurology, Medical College
at the Jagiellonian University. Neurological examinations
and neuroimaging were performed at least twice (at the
acute phase and during follow-up). The stroke subtypes
were evaluated using the Oxfordshire classification [16].
The control group of 50 children was age- and sex-
matched (26 males, 24 females, age ranging from 1 to
18 years, mean 9.0 ± 6.1). These children had no signs
of ischaemic stroke or other vascular diseases.
The study protocol was approved by the Ethics
Committee of the Medical University of Silesia in Kato-
wice and written consent was provided by the parents of
the patients.
Genetic analysis
Genomic DNA was extracted from peripheral leu-
cocytes. The C242T polymorphism of the CYBA gene
was genotyped using PCR-RFLP (polymerase chain
reaction – restriction fragment length polymorphism),
with RsaI as a restrictase. The method was previously
described in detail, including reagents used [17]. 
Statistical analysis
The statistical methods were also previously descri-
bed in detail [5]. Briefly, the role of C242T polymor-
phism in paediatric ischaemic stroke has been tested by
two independent methods: a family-based association test
– the transmission/disequilibrium test (TDT); and the
classical case-control model. Transmission of a particu-
lar allele from heterozygous parents to an offspring is
expected to be approximately 50%, when there is no asso-
ciation of the allele and the disease. If the allele is asso-
ciated with an increased risk of the disease, excess trans-
mission to the offspring is expected. The observed
frequencies of transmitted alleles were compared with
the expected frequencies by means of the χ2 test. Simi-
larly, the χ2 test was used in the case-control model. Odds
ratios (OR) as well as their 95% confidence intervals (CI)
for CYBA genotypes were computed using univariate
regression model analysis. Statistica 7.1 software 
(STATSOFT, Tulsa, OK) was used in all analyses.
Results
Clinical analysis
Clinical characteristics of stroke children are shown
in Table 1. The main symptoms of the onset of stroke
were: central facial palsy, hemiparesis, consciousness
disturbances and aphasia. The most frequent were inci-
dents of partial anterior circulation infarct. The most
frequent post-stroke symptoms diagnosed during 
follow-up examination were: hemiparesis, epilepsy and
Demographics Stroke group
n 70
Sex (male/female) 41/29
Age at the time of stroke, years (mean ± SD) 8.48 ± 5.44
Symptoms and signs at the time of stroke*, n (%)
Hemiplegia 9 (14.8)
Hemiparesis 45 (73.8)
Central facial palsy 50 (83.6)
Consciousness disturbances 38 (62.3)
Vertigo/dizziness 31 (50.8)
Aphasia 35 (57.4)
Other stroke symptoms 29 (47.5)
Type of stroke*, n (%) 
Total anterior circulation infarct 13 (21.3)
Partial anterior circulation infarct 24 (39.3)
Lacunar infarct 15 (24.6)
Posterior circulation infarct 9 (14.8)
Symptoms and signs at the time of follow-up examination*, 
n (%)
Hemiparesis 45 (73.8)
Epilepsy 9 (14.8)
Other movement disorders 14 (23.0)
Decrease of intellectual functioning 13 (21.3)
Dysarthria 4 (6.6)
Table 1. Clinical characteristics of children with ischaemic stroke
*Data available from 61 patients
SD – standard deviation
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other movement disorders and decrease of intellectual
functioning. As previously reported, more than 67% of 
the stroke patients had lipometabolic disorders [5]. 
Genotype analysis
The genotype frequencies were consistent with the
Hardy-Weinberg equilibrium in the patients (p = 0.66)
and in the control group (p = 0.47). In the transmis-
sion disequilibrium test, 50 full families were finally
qualified, yielding 33 informative trios, defined as fami-
lies with at least one heterozygous parent. Only in such
informative families was it possible to deduce which 
allele had been transmitted from a parent to the child. 
The number of transmitted alleles was 28 for the C242
allele (62.2%) and 17 for the 242T allele (37.8%). 
The C242 allele was transmitted more frequently but
the observed frequencies of both alleles did not differ
significantly from expected (χ2 = 2.68, p = 0.10 for
both alleles) (Table 2). 
Data from genotyping of the CYBA gene C242T
polymorphism are shown in Table 3. We did not observe
any statistical differences in the distribution of genotypes
and alleles between stroke children and controls (Table 3).
There were no differences in the distribution of genoty-
pes and alleles of the C242T CYBA polymorphism bet -
ween respective stroke classes as well as symptoms of the
onset of stroke and post-stroke symptoms diagnosed
during follow-up examination (data not shown). 
Discussion
The substitution in the 242 nucleotide position of
the CYBA gene results in differences in superoxide syn-
thesis by NAD(P)H oxidases. Although there are con-
flicting results from functional studies on the C242T
polymorphism [18-21], enhanced superoxide anion pro-
duction and increased low density lipoprotein oxidation
are more often attributed to the 242T allele [19-21].
There are no references in the literature to CYBA
C242T polymorphism in paediatric ischaemic stroke
patients. Previous studies in stroke patients were not
numerous and were conducted in adults, with non-com-
parable results due to ethnic differences. Most of the
studies concerned the Japanese population, where the
242T allele was associated with ischaemic stroke in one
report [22]. Another two Japanese reports did not asso-
ciate the C242T polymorphism with stroke [19,23].
Only one study was conducted in a Caucasian popula-
tion of patients with ischaemic stroke or transient ischa-
emic attack under the age of 50 years. The authors
found that homozygosity of the 242T variant was asso-
ciated with an enhanced risk for cerebral ischaemia [24]. 
The present study did not reveal statistically signi-
ficant differences in the frequency of transmission betwe-
en C242 and 242T alleles in the TDT analysis
(p = 0.10). There was, however, a tendency to marke-
dly preferential transmission of the C242 allele from
heterozygous parents to affected children (62.2% for
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*Comparison of stroke children with the controls
Allele Transmitted (n) Not transmitted (n) Predicted (n) χ2 p-value
C242 28 17 22.5 2.69 0.10
242T 17 28 22.5 2.69 0.10
Table 2. Transmission disequilibrium test for CYBA alleles in children with ischaemic stroke
Genotype/ allele Children with stroke  Control group Stroke/controls*
n (%) n (%) χ2 p-value
CC 35 (50.0) 26 (52.0) 0.05 0.83
CT 27 (38.6) 18 (36.0) – –
TT 8 (11.4) 6 (12.0) 0.01 0.92
C242 97 (69.3) 70 (70.0) 0.01 0.91
242T 43 (30.7) 30 (30.0) 0.01 0.91
Table 3. Distribution of genotypes and alleles of the C242T polymorphism of the CYBA gene
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C242 allele vs. 37.8% for 242T allele). The case-con-
trol model also did not reveal any statistically significant
differences in the distribution of alleles and genotypes
between patients and controls. The cause of the case-
control analysis results may be the specificity of CYBA
polymorphism, the phenotype of which is probably
manifested during exposure to NAD(P)H oxidase acti-
vators, such as thrombin, hyperglycaemia, hyperchole-
sterolaemia or cigarette smoking. We previously showed
that the 242T allele interacts synergistically with some
of these agents, significantly increasing the risk of coro-
nary artery disease [17], and the observed effects were
not related to absolute values of allele/genotype frequ-
encies (no differences between groups in the case-con-
trol model) but resulted from interactions between ele-
vated superoxide anion production by the 242T allele,
hypercholesterolaemia and cigarette smoking [17]. 
Although the role of ROS in the physiology and
pathology of coronary arteries is rather well under stood,
their effects on the cerebral circulation are complex and
have not been fully defined. Superoxide and hydrogen
peroxide, a product of superoxide anion dismutation,
are involved in many pathological actions including:
endothelial damage; vasoconstriction; stimulation of
expression of adhesion molecules, chemoattractants and
matrix metalloproteinases (MMPs); hypertrophy and
proliferation of vascular smooth muscle cells; and low
density lipoprotein oxidation [8-10]. Additionally, the
oxidase-derived ROS induce the expression of tissue
factor, the main initiator of the blood coagulation casca-
de [11], and promote platelet aggregation [12], which
may be a potential link between oxidative stress and
ischaemic stroke, including in children.
On the other hand, there is growing evidence sug-
gesting that NAD(P)H oxidase-derived ROS may
serve as physiological regulators of cerebral arteries. The
NAD(P)H oxidases are expressed constitutively in the
cerebral vasculature and the enzyme-dependent O2
–
production is up to 90-fold greater in intracranial cere-
bral arteries (i.e. basilar and middle cerebral) versus non-
cerebral arteries (i.e. aorta, common carotid) at physio-
logical level [14]. Both superoxide and hydrogen
peroxide regulate cerebrovascular tone and its effect is
probably concentration-dependent, with relaxation of
vascular smooth muscle cells occurring at low concen-
trations and contraction of arteries at higher concentra-
tions [6,7,14]. 
We observed elevated, but not statistically signifi-
cantly, transmission of the C242 allele, which is asso-
ciated with decreased O2
– production. The classical risk
factors of atherosclerosis seem to be a rather marginal
cause of paediatric stroke, as mentioned above. So we
may assume that the chronic and maintaining vasocon-
striction associated with 242T allele-related elevated O2
–
production, which increases the effect of classical risk
factors, is a rather infrequent phenomenon in children.
It is more probable that the vasoconstriction of infan-
tile cerebral arteries will be related to decreased levels of
vasodilatative reactive oxygen species, partly associated
with the phenotypic manifestation of C242 allele pre-
sence. 
Although our understanding of the role of ROS in
paediatric ischaemic stroke is fragmentary and extrapo-
lated from the studies on tissues, animal models and
adults, it seems very likely that local changes in con-
centration of free radicals can increase the inter-indivi-
dual predisposition to early children’s ischaemic stroke.
However, to date, there are no simple methods to veri-
fy these speculations. In conclusion, the CYBA gene
C242T polymorphism seems not to be a good predic-
tor of paediatric ischaemic stroke; the results of the pre-
sent work, however, should not discourage researchers
to study the role of reactive oxygen species and
NAD(P)H oxidases in the context of paediatric ischa-
emic stroke.  
The main limitation of this study is the number of
included patients. It should be pointed out, however,
that the participants were recruited through cooperation
with four major neurology centres in Poland. The low
frequency of paediatric stroke (2-4/100 000/year) and
a methodology requiring whole families were the main
obstacles to enlargement of the patient group.
Conclusions
The study did not show that the C242T polymor-
phism of the CYBA gene is a risk factor of ischaemic
stroke in children.
Acknowledgements
This study was supported within the project KNW-
2-020/08 of the Medical University of Silesia. Prelimi-
nary data were presented at the XLIV Annual Meeting
of the Polish Biochemical Society in Lodz, 2009.
Disclosure
The authors report no conflict of interest.
Neurologia i Neurochirurgia Polska 2010; 44, 5458
Pawe³ Niemiec, Iwona ¯ak, Ewa Emich-Widera, Anna Balcerzyk, Ilona Kopyta, Tomasz Nowak, Jerzy Wendorff, Katarzyna Pa³atyñska, Marek Kaciñski, Karolina Pienczk-Rêc³awowicz, 
Ewa Pilarska
References
1. Pavlakis S.G., Kingsley P.B., Bialer M.G. Stroke in children:
genetic and metabolic issues J Child Neurol 2000; 15: 308-315.
2. Kirkham F., Sébire G., Steinlin M., et al. Arterial ischaemic
stroke in children. Review of the literature and strategies for
future stroke studies. Thromb Haemost 2004; 92: 697-706. 
3. Jêdrzejewska J., Cz³onkowska A., Kobayashi A. Pomostowanie
aortalno-wieñcowe u osób z objawowym lub bezobjawowym
zwê¿eniem têtnicy szyjnej wewnêtrznej [Article in Polish]. Neurol
Neurochir Pol 2009; 43: 263-271.
4. Kopyta I., Marszal E. Czynniki ryzyka udaru mózgu u dzieci
[Article in Polish]. Udar Mozgu 2004; 6: 47-55.
5. Balcerzyk A., Zak I., Niemiec P., et al. APOE gene e
polymorphism does not determine predisposition to ischemic
stroke in children. Pediatr Neurol 2010; 43: 25-28.
6. Miller A.A., Drummond G.R, Sobey C.G. Novel isoforms of
NADPH-oxidase in cerebral vascular control. Pharmacol Ther
2006; 111: 928-948.
7. Miller A.A., Drummond G.R., Sobey C.G. Reactive oxygen
species in the cerebral circulation: are they all bad? Antioxid Redox
Signal 2006; 8: 1113-1120.
8. Niemiec P., Zak I. Naczyniowe oksydazy NAD(P)H –
znaczenie w patogenezie mia¿d¿ycy [Article in Polish]. Postepy
Bio chem 2005; 51: 1-11.
9. Lassegue B., Clempus R.E. Vascular NAD(P)H oxidases:
specific features, expression, and regulation. Am J Physiol Regul
Integr Comp Physiol 2003; 285: R277-R297.
10. Guzik T.J., West N.E., Black E., et al. Vascular superoxide
production by NAD(P)H oxidase: association with endothelial
dysfunction and clinical risk factors. Circ Res 2000; 86: E85-E90.
11. Herkert O., Diebold I., Brandes R.P., et al. NADPH oxidase
mediates tissue factor-dependent surface procoagulant activity
by thrombin in human vascular smooth muscle cells. Circulation
2002; 105: 2030-2036.
12. Krötz F., Sohn H.Y., Gloe T. NAD(P)H oxidase-dependent
platelet superoxide anion release increases platelet recruitment.
Blood 2002; 100: 917-924.
13. Alexandrova M., Bochev P., Markova V., et al. Dynamics of free
radical processes in acute ischemic stroke: influence on neu -
rological status and outcome. J Clin Neurosci 2004; 11: 501-506.
14. Miller A.A., Drummond G.R., Schmidt H.H., et al. NADPH
oxidase activity and function are profoundly greater in cerebral
versus systemic arteries. Circ Res 2005; 97: 1055-1062.
15. Dinauer M.C., Pierce E.A., Bruns G.A., et al. Human
neutrophil cytochrome b light chain (p22-phox). Gene structure,
chromosomal location, and mutations in cytochrome-negative
autosomal recessive chronic granulomatous disease. J Clin Invest
1990; 86: 1729-1737.
16. Pittock S.J., Meldrum D., Hardiman O., et al. The Oxfordshire
Community Stroke Project classification: correlation with
imaging, associated complications, and prediction of outcome in
acute ischemic stroke. J Stroke Cerebrovasc Dis 2003; 12: 1-7. 
17. Niemiec P., Zak I., Wita K. The 242T variant of the CYBA gene
polymorphism increases the risk of coronary artery disease
associated with cigarette smoking and hypercholesterolemia.
Coron Artery Dis 2007; 18: 339-346.
18. Wyche K.E., Wang S.S., Griendling K.K., et al. C242T CYBA
polymorphism of the NADPH oxidase is associated with
reduced respiratory burst in human neutrophils. Hypertension
2004; 43: 1246-1251.
19. Shimo-Nakanishi Y., Hasebe T., Suzuki A., et al. Functional
effects of NAD(P)H oxidase p22(phox) C242T mutation in
human leukocytes and association with thrombotic cerebral
infarction. Atherosclerosis 2004; 175: 109-115.
20. Macías-Reyes A., Rodríguez-Esparragón F., Caballero-Hidal -
go A., et al. Insight into the role of CYBA A640G and C242T
gene variants and coronary heart disease risk. A case-control
study. Free Radic Res 2008; 42: 82-92.
21. Nakano T., Matsunaga S., Nagata A., et al. NAD(P)H oxidase
p22phox Gene C242T polymorphism and lipoprotein oxidation.
Clin Chim Acta 2003; 335:101-107.
22. Ito D., Murata M., Watanabe K., et al. C242T polymorphism
of NADPH oxidase p22 PHOX gene and ischemic
cerebrovascular disease in the Japanese population. Stroke 2000;
31: 936-939.
23. Kuroda J., Kitazono T., Ago T., et al. NAD(P)H oxidase
p22phox C242T polymorphism and ischemic stroke in Japan:
the Fukuoka Stroke Registry and the Hisayama study. Eur 
J Neurol  2007; 14: 1091-1097.
24. Genius J., Grau A.J., Lichy C. The C242T polymorphism of
the NAD(P)H oxidase p22phox subunit is associated with an
enhanced risk for cerebrovascular disease at a young age.
Cerebrovasc Dis 2008; 26: 430-433.
